Maykin Ho Agios Pharmaceuticals, Inc. (AGIO) insider trading activity

AGIO Quotes by TradingView

Maykin Ho is Director of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 17,032 shares of AGIO, which is worth approximately $687,241. The most recent transaction as insider was on Jun 20, 2025, when has been sold 2,120 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17K
14.22% 3M change
14.22% 12M change
Total Value Held $687,241

Maykin Ho Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 20 2025
BUY
Exercise of conversion of derivative security
-
2,120 Added 11.07%
17,032 Common Stock
Jun 13 2024
BUY
Exercise of conversion of derivative security
-
3,388 Added 18.51%
14,912 Common Stock
Jun 21 2023
BUY
Exercise of conversion of derivative security
-
4,975 Added 30.15%
11,524 Common Stock
May 20 2022
BUY
Exercise of conversion of derivative security
-
1,585 Added 19.49%
6,549 Common Stock
May 28 2021
BUY
Exercise of conversion of derivative security
-
1,686 Added 25.35%
4,964 Common Stock

Also insider at

BMRN
BIOMARIN PHARMACEUTICAL INC Healthcare
Director
FGEN
FIBROGEN INC Healthcare
NMRA
Neumora Therapeutics, Inc.
MH

Maykin Ho

Director
Novato, CA

Track Institutional and Insider Activities on AGIO

Follow AGIOS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGIO